A “superhero” delivery driver in Hanoi has saved a two-year-old girl who fell from a 12th-floor balcony.
Nguyen Ngoc Manh, 31, was sitting in his car waiting to make a delivery at 5pm on Sunday when he heard a child crying, he told the Anninhthudo news organization.
A woman started screaming and he stuck his head out of the window to see what was going on.
He told local media in the Vietnamese capital that he first thought it was a child having a tantrum, but quickly realized it was something else.
The child was nearly 50m above ground.
“I saw a girl climbing out of the balcony,” he said.
He jumped out of his car and climbed up on to a nearby building to get closer should the child fall.
“I mounted a 2m-high tile roof to seek a proper position to get the girl,” he said, still trembling from the rescue, according to the Vietnam Times.
Standing on a metallic roof used to store generators, he lost his footing as the child began to fall, but he flung himself forward to catch her, landing so hard that he left a dent in the roof, he told VN Express International.
“I tried to reach out my hand and took the maximum effort to catch the girl,” he said, hoping that at the very least he might be able to prevent her from falling straight to the ground.
In a video of the incident taken from a nearby apartment building, the child can be seen climbing over the balcony railing and on to a thin ledge.
Neighbors in a building opposite can be heard crying out to her. The child holds on for a few moments before losing her grip and falling.
“Luckily, the baby fell into my lap,” Nguyen said.
“I hurriedly embraced her, then saw blood leaking from her mouth, I was very frightened,” he added.
The child was taken to the National Children’s Hospital where doctors told local media she had dislocated her hip, but suffered no other injuries.
Le Ngoc Duy, a doctor at the hospital, said she was in a cast and being monitored.
The COVID-19 variant discovered in South Africa can “break through” Pfizer-BioNTech’s COVID-19 vaccine to some extent, a real-world data study released on Saturday found, although its prevalence in the country is low and the research has not been peer reviewed. The study in Israel compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated people with the disease. It matched age and gender, among other characteristics. The South African variant, B.1.351, was found to make up about 1 percent of all the COVID-19
RARE ADMISSION: A top Chinese expert was the first to publicly address the efficacy of the nation’s vaccines as it aims to inoculate 40 percent of its population by June China is considering mixing different COVID-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert told a conference in Chengdu on Saturday. Authorities have to “consider ways to solve the issue that efficacy rates of existing vaccines are not high,” Chinese media outlet The Paper reported, citing Chinese Center for Disease Control and Prevention Director Gao Fu (高福). His comments mark the first time a top Chinese expert has publicly alluded to the relatively low efficacy of the country’s vaccines, as China forges ahead in its mass vaccination campaign and exports its jabs around the world. China
The Australian government yesterday said that it had decided against buying the single-dose Johnson & Johnson (J&J) COVID-19 vaccine and identified a second case of a rare blood clot likely linked to the AstraZeneca shot. The Australian government had been in talks with the New Jersey-based pharmaceutical giant, which had asked the Australian Therapeutic Goods Administration for provisional registration. However, Australian Minister of Health Greg Hunt ruled out a J&J contract, because its vaccine was similar to the AstraZeneca product, which Australia had already contracted for 53.8 million doses. Hunt said the government was following the advice of Australia’s scientific and technical advisory
The Indonesian government has said it is satisfied with the effectiveness of the Chinese COVID-19 vaccine it has been using, after China’s top disease control official said that current vaccines offer low protection against the novel coronavirus. Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine program, on Monday said the WHO had found that the Chinese vaccines had met requirements by being more than 50 percent effective. Clinical trials in Indonesia for the vaccine from Chinese drugmaker Sinovac showed that it was 65 percent effective, she said. “It means ... the ability to form antibodies in our bodies is still very